Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2Phase 3 Interventional Results available

Addressing Dementia Via Agitation-Centered Evaluation

ClinicalTrials.gov ID: NCT03226522

Public ClinicalTrials.gov record NCT03226522. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 8:31 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of AXS-05 for the Treatment of Agitation in Subjects With Dementia of the Alzheimer's Type

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a multi-center, randomized, double-blind, placebo-controlled study, to assess the efficacy and safety of AXS-05 in the treatment of agitation in patients with Alzheimer's disease.

Study identification

NCT ID
NCT03226522
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
Axsome Therapeutics, Inc.
Industry
Enrollment
366 participants

Conditions and interventions

Eligibility (public fields only)

Age range
65 Years to 90 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 13, 2017 (Actual)
Primary completion
Apr 17, 2020 (Actual)
Completion
Apr 17, 2020 (Actual)
Last update posted
Sep 13, 2023

2017 – 2020

United States locations

U.S. sites
77
U.S. states
25
U.S. cities
70
Facility City State ZIP Site status
Axsome Study Site Gilbert Arizona 85297 —
Axsome Study Site Phoenix Arizona 85004 —
Axsome study site Scottsdale Arizona 85251 —
Axsome study site Scottsdale Arizona 85258 —
Axsome Study Site Tucson Arizona 85704 —
Axsome Study Site Little Rock Arkansas 72209 —
Axsome study site Canoga Park California 91303 —
Axsome study site Costa Mesa California 92626 —
Axsome study site Fresno California 93710 —
Axsome study site Long Beach California 90806 —
Axsome study site Long Beach California 90807 —
Axsome Study Site Los Alamitos California 90720 —
Axsome study site Riverside California 92503 —
Axsome study site Sacramento California 95821 —
Axsome study site Santa Ana California 92705 —
Axsome Study Site Santa Clarita California 91321 —
Axsome study site Sherman Oaks California 91403 —
Axsome study site Simi Valley California 93065 —
Axsome study site Temecula California 92591 —
Axsome study site Ventura California 93003 —
Axsome Study Site Colorado Springs Colorado 80910 —
Axsome study site Cromwell Connecticut 06416 —
Axsome study site New London Connecticut 06320 —
Axsome Study Site Apopka Florida 32703 —
Axsome study site Boca Raton Florida 33487 —
Axsome study site Boynton Beach Florida 33437 —
Axsome Study Site Coconut Creek Florida 33066 —
Axsome Study Site Greenacres City Florida 33467 —
Axsome study site Hallandale Florida 33009 —
Axsome study site Hialeah Florida 33012 —
Axsome Study Site Lake City Florida 32055 —
Axsome study site Miami Florida 33122 —
Axsome study site Miami Florida 33165 —
Axsome Study Site Orlando Florida 32807 —
Axsome study site Pensacola Florida 32502 —
Axsome Study Site Port Orange Florida 32127 —
Axsome study site Spring Hill Florida 34609 —
Axsome study site Tampa Florida 33609 —
Axsome study site Tampa Florida 33613 —
Axsome study site Atlanta Georgia 30331 —
Axsome study site Decatur Georgia 30030 —
Axsome Study Site Honolulu Hawaii 96817 —
Axsome study site Boise Idaho 83704 —
Axsome Study Site Flossmoor Illinois 60422 —
Axsome study site Avon Indiana 46123 —
Axsome Study Site Overland Park Kansas 66212 —
Axsome Study Site Topeka Kansas 66606 —
Axsome study site Baton Rouge Louisiana 70808 —
Axsome Study Site Lake Charles Louisiana 70629 —
Axsome Study Site Hattiesburg Mississippi 39401 —
Axsome study site Chesterfield Missouri 63005 —
Axsome Study Site St Louis Missouri 63128 —
Axsome study site Las Vegas Nevada 89102 —
Axsome Study Site Las Vegas Nevada 89109 —
Axsome Study Site Princeton New Jersey 08540 —
Axsome study site Toms River New Jersey 08755 —
Axsome Study Site Albany New York 12208 —
Axsome study site Brooklyn New York 11229 —
Axsome study site New York New York 10036 —
Axsome study site New York New York 10128 —
Axsome study site Staten Island New York 10312 —
Axsome Study Site Charlotte North Carolina 28211 —
Axsome study site Charlotte North Carolina 28270 —
Axsome Study Site Winston-Salem North Carolina 27103 —
Axsome study site Cincinnati Ohio 45069 —
Axsome Study Site Dayton Ohio 45459 —
Axsome study site Shaker Heights Ohio 44122 —
Axsome Study Site Oklahoma City Oklahoma 73112 —
Axsome study site DeSoto Texas 75115 —
Axsome Study Site McKinney Texas 75071 —
Axsome study site Wichita Falls Texas 76309 —
Axsome study site Orem Utah 84058 —
Axsome Study Site Charlottesville Virginia 22903 —
Axsome Study Site Richmond Virginia 23235 —
Axsome study site Bellevue Washington 98007 —
Axsome Study Site Everett Washington 98201 —
Axsome study site Spokane Washington 99202 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03226522, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 13, 2023 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03226522 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →